|
Index of reports
> Cases with Parkinson's Disease (15)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Requip (Ropinirole) where reactions include parkinson's disease. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Requip side effects in
Reported by a consumer/non-health professional from Germany on 2012-06-12
Patient:
Reactions: Parkinson's Disease, Drug Interaction, Gait Disturbance
Drug(s) suspected as cause:
Azilect
Dosage: 1mg per day
Requip
Dosage: 8mg per day
Administration route: Oral
Indication: Parkinson's Disease
Madopar Depot
Seroquel
Dosage: 200mg per day
Indication: Bipolar Disorder
Start date: 2012-03-01
Stalevo 100
Dosage: 100mg five times per day
Other drugs received by patient: Levothyroxine Sodium
Possible Requip side effects in female
Reported by a physician from United States on 2012-06-06
Patient: female
Reactions: Pruritus, Pain in Extremity, Incorrect Dose Administered, Parkinson's Disease, Nerve Compression, Tremor, Disease Complication, Feeling Abnormal
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Stalevo 100
Dosage: 100 mg, unk
Administration route: Oral
Requip
Possible Requip side effects in
Reported by a consumer/non-health professional from Germany on 2012-05-21
Patient:
Reactions: Parkinson's Disease, Gait Disturbance
Drug(s) suspected as cause:
Requip
Dosage: 8mg per day
Administration route: Oral
Indication: Parkinson's Disease
Seroquel
Dosage: 200mg per day
Indication: Bipolar Disorder
Start date: 2012-03-01
Azilect
Dosage: 1mg per day
Stalevo 100
Dosage: 100mg five times per day
Madopar Depot
Other drugs received by patient: Levothyroxine Sodium
Possible Requip side effects in 71 year old male
Reported by a consumer/non-health professional from Germany on 2012-05-03
Patient: 71 year old male
Reactions: Hypokinesia, Pain in Extremity, Drug Ineffective, Multiple System Atrophy, Parkinson's Disease, Spinal Osteoarthritis, Bladder Disorder
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Requip
Other drugs received by patient: Amantadine HCL; Tilidine / Naloxone; Lisinopril; Amlodipine; Carbidopa and Levodopa; Aspirin; Lisihexal; Pantoprazole
Possible Requip side effects in female
Reported by a pharmacist from Japan on 2012-04-23
Patient: female
Reactions: Camptocormia, Parkinson's Disease, Mobility Decreased
Drug(s) suspected as cause:
Requip
Other drugs received by patient: Carbidopa and Levodopa; Symmetrel
Possible Requip side effects in 75 year old female
Reported by a pharmacist from Japan on 2012-04-17
Patient: 75 year old female
Reactions: Camptocormia, Parkinson's Disease, Mobility Decreased
Drug(s) suspected as cause:
Requip
Possible Requip side effects in 75 year old female
Reported by a pharmacist from Japan on 2012-04-13
Patient: 75 year old female
Reactions: Dysstasia, Parkinson's Disease, Camptocormia, Mobility Decreased
Drug(s) suspected as cause:
Requip
Possible Requip side effects in
Reported by a pharmacist from Korea, Republic of on 2012-02-15
Patient:
Reactions: Parkinson's Disease
Drug(s) suspected as cause:
Requip
Possible Requip side effects in male
Reported by a consumer/non-health professional from United Kingdom on 2012-02-03
Patient: male, weighing 78.0 kg (171.6 pounds)
Reactions: Movement Disorder, Drug Level Fluctuating, Drug Ineffective, Dysphonia, Parkinson's Disease, Tremor
Drug(s) suspected as cause:
Requip
Other drugs received by patient: Methotrexate; Fluticasone Propionate; Adalimumab; Rynacrom; Atorvastatin; Cetirizine
Possible Requip side effects in male
Reported by a pharmacist from United Kingdom on 2012-01-11
Patient: male
Reactions: Drug Level Fluctuating, Movement Disorder, Drug Ineffective, Dysphonia, Parkinson's Disease, Tremor
Drug(s) suspected as cause:
Requip
Other drugs received by patient: Methotrexate; Fluticasone Propionate; Cetirizine; Adalimumab; Atorvastatin; Rynacrom
Possible Requip side effects in 75 year old male
Reported by a consumer/non-health professional from United States on 2012-01-05
Patient: 75 year old male
Reactions: Parkinson's Disease, Diabetic Complication, Chronic Obstructive Pulmonary Disease
Adverse event resulted in: death
Drug(s) suspected as cause:
Requip
Other drugs received by patient: Multiple Medications
Possible Requip side effects in male
Reported by a consumer/non-health professional from United Kingdom on 2011-12-01
Patient: male
Reactions: Movement Disorder, Drug Level Fluctuating, Drug Ineffective, Dysphonia, Parkinson's Disease, Tremor
Drug(s) suspected as cause:
Requip
Other drugs received by patient: Fluticasone Propionate; Adalimumab; Atorvastatin; Cetirizine HCL; Ranitidine; Methotrexate
Possible Requip side effects in female
Reported by a pharmacist from Japan on 2011-10-28
Patient: female
Reactions: Parkinson's Disease
Drug(s) suspected as cause:
Requip
Dosage: 2mg per day
Administration route: Oral
Indication: Parkinson's Disease
EC Doparl
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Selegiline HCL
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Rabeprazole Sodium
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-01-01
Comtan
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Possible Requip side effects in 75 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2011-10-26
Patient: 75 year old male
Reactions: Parkinson's Disease, Diabetic Complication, Chronic Obstructive Pulmonary Disease
Adverse event resulted in: death
Drug(s) suspected as cause:
Requip
Other drugs received by patient: Multiple Medications
Possible Requip side effects in
Reported by a pharmacist from Japan on 2011-10-20
Patient:
Reactions: Parkinson's Disease
Drug(s) suspected as cause:
Selegiline HCL
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Requip
Dosage: 2mg per day
Administration route: Oral
Indication: Parkinson's Disease
Rabeprazole Sodium
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-01-01
Comtan
Administration route: Oral
Indication: Product Used FOR Unknown Indication
EC Doparl
Administration route: Oral
Indication: Product Used FOR Unknown Indication
|
